[1]
2021. Efficacy and safety of anlotinib in patients with advanced colorectal cancer and analysis of prognostic factors. Indian Journal of Experimental Biology (IJEB). 59, 10 (Oct. 2021), 740–744. DOI:https://doi.org/10.56042/ijeb.v59i10.55805.